11179983

Source:http://linkedlifedata.com/resource/pubmed/id/11179983

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002645, umls-concept:C0025872, umls-concept:C0028978, umls-concept:C0178602, umls-concept:C0850666, umls-concept:C1280500, umls-concept:C1424986, umls-concept:C1442162, umls-concept:C1550718, umls-concept:C1880198, umls-concept:C2603343
pubmed:issue	4
pubmed:dateCreated	2001-2-22
pubmed:abstractText	Helicobacter pylori eradication with omeprazole, amoxycillin, and metronidazole is both effective and inexpensive. However, eradication rates with different dosages and dosing vary, and data on the impact of resistance are sparse. In this study, three different dosages of omeprazole, amoxycillin, and metronidazole were compared, and the influence of metronidazole resistance on eradication was assessed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9605411
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents, http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole, http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1083-4389
pubmed:author	pubmed-author:BardhanKK, pubmed-author:BayerdörfferEE, pubmed-author:BurmanC FCF, pubmed-author:DelchierJ CJC, pubmed-author:GromarkPP, pubmed-author:HellblomMM, pubmed-author:LindTT, pubmed-author:MégraudFF, pubmed-author:StubberödAA, pubmed-author:Veldhuyzen Van ZantenS JSJ, pubmed-author:ZeijlonLL
pubmed:issnType	Print
pubmed:volume	5
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	196-201
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11179983-Adolescent, pubmed-meshheading:11179983-Adult, pubmed-meshheading:11179983-Aged, pubmed-meshheading:11179983-Amoxicillin, pubmed-meshheading:11179983-Anti-Bacterial Agents, pubmed-meshheading:11179983-Anti-Ulcer Agents, pubmed-meshheading:11179983-Child, pubmed-meshheading:11179983-Child, Preschool, pubmed-meshheading:11179983-Drug Resistance, Microbial, pubmed-meshheading:11179983-Drug Therapy, Combination, pubmed-meshheading:11179983-Helicobacter Infections, pubmed-meshheading:11179983-Helicobacter pylori, pubmed-meshheading:11179983-Humans, pubmed-meshheading:11179983-Infant, pubmed-meshheading:11179983-Infant, Newborn, pubmed-meshheading:11179983-Male, pubmed-meshheading:11179983-Metronidazole, pubmed-meshheading:11179983-Middle Aged, pubmed-meshheading:11179983-Omeprazole, pubmed-meshheading:11179983-Treatment Outcome
pubmed:year	2000
pubmed:articleTitle	The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
pubmed:affiliation	Rotherham District General Hospital, Rotherham, UK.
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't